BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 34004208)

  • 1. Stable desensitization of α
    Pismataro MC; Horenstein NA; Stokes C; Dallanoce C; Thakur GA; Papke RL
    Eur J Pharmacol; 2021 Aug; 905():174179. PubMed ID: 34004208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allosteric Agonism of
    Gulsevin A; Papke RL; Stokes C; Garai S; Thakur GA; Quadri M; Horenstein NA
    Mol Pharmacol; 2019 Jun; 95(6):606-614. PubMed ID: 30944209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NS6740, an α7 nicotinic acetylcholine receptor silent agonist, disrupts hippocampal synaptic plasticity.
    Papke RL; Peng C; Kumar A; Stokes C
    Neurosci Lett; 2018 Jun; 677():6-13. PubMed ID: 29679680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent activation of α7 nicotinic ACh receptors associated with stable induction of different desensitized states.
    Papke RL; Stokes C; Damaj MI; Thakur GA; Manther K; Treinin M; Bagdas D; Kulkarni AR; Horenstein NA
    Br J Pharmacol; 2018 Jun; 175(11):1838-1854. PubMed ID: 28477386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding Interactions of NS6740, a Silent Agonist of the
    Blunt CEW; Dougherty DA
    Mol Pharmacol; 2019 Aug; 96(2):212-218. PubMed ID: 31175182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical Molecular Determinants of α7 Nicotinic Acetylcholine Receptor Allosteric Activation: SEPARATION OF DIRECT ALLOSTERIC ACTIVATION AND POSITIVE ALLOSTERIC MODULATION.
    Horenstein NA; Papke RL; Kulkarni AR; Chaturbhuj GU; Stokes C; Manther K; Thakur GA
    J Biol Chem; 2016 Mar; 291(10):5049-67. PubMed ID: 26742843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The analgesic-like properties of the alpha7 nAChR silent agonist NS6740 is associated with non-conducting conformations of the receptor.
    Papke RL; Bagdas D; Kulkarni AR; Gould T; AlSharari SD; Thakur GA; Damaj MI
    Neuropharmacology; 2015 Apr; 91():34-42. PubMed ID: 25497451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Competitive binding at a nicotinic receptor transmembrane site of two α7-selective positive allosteric modulators with differing effects on agonist-evoked desensitization.
    Collins T; Young GT; Millar NS
    Neuropharmacology; 2011 Dec; 61(8):1306-13. PubMed ID: 21820451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, and electrophysiological evaluation of NS6740 derivatives: Exploration of the structure-activity relationship for alpha7 nicotinic acetylcholine receptor silent activation.
    Pismataro MC; Horenstein NA; Stokes C; Quadri M; De Amici M; Papke RL; Dallanoce C
    Eur J Med Chem; 2020 Nov; 205():112669. PubMed ID: 32810771
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silent agonists for α7 nicotinic acetylcholine receptors.
    Papke RL; Quadri M; Gulsevin A
    Pharmacol Res; 2023 Apr; 190():106736. PubMed ID: 36940890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential Activation and Desensitization States Promoted by Noncanonical
    Stokes C; Camacho-Hernandez GA; Thakur GA; Wu X; Taylor P; Papke RL
    J Pharmacol Exp Ther; 2022 Nov; 383(2):157-171. PubMed ID: 36279397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of the molecular mechanism of the α7 nicotinic acetylcholine receptor positive allosteric modulator PNU-120596 provides evidence for two distinct desensitized states.
    Williams DK; Wang J; Papke RL
    Mol Pharmacol; 2011 Dec; 80(6):1013-32. PubMed ID: 21885620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of channel activation in cognitive enhancement mediated by alpha7 nicotinic acetylcholine receptors.
    Briggs CA; Grønlien JH; Curzon P; Timmermann DB; Ween H; Thorin-Hagene K; Kerr P; Anderson DJ; Malysz J; Dyhring T; Olsen GM; Peters D; Bunnelle WH; Gopalakrishnan M
    Br J Pharmacol; 2009 Nov; 158(6):1486-94. PubMed ID: 19845675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The activity of GAT107, an allosteric activator and positive modulator of α7 nicotinic acetylcholine receptors (nAChR), is regulated by aromatic amino acids that span the subunit interface.
    Papke RL; Horenstein NA; Kulkarni AR; Stokes C; Corrie LW; Maeng CY; Thakur GA
    J Biol Chem; 2014 Feb; 289(7):4515-31. PubMed ID: 24362025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mode of action of the positive modulator PNU-120596 on α7 nicotinic acetylcholine receptors.
    Szabo AK; Pesti K; Mike A; Vizi ES
    Neuropharmacology; 2014 Jun; 81():42-54. PubMed ID: 24486377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An Unaltered Orthosteric Site and a Network of Long-Range Allosteric Interactions for PNU-120596 in α7 Nicotinic Acetylcholine Receptors.
    Marotta CB; Lester HA; Dougherty DA
    Chem Biol; 2015 Aug; 22(8):1063-73. PubMed ID: 26211363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agonist activation of alpha7 nicotinic acetylcholine receptors via an allosteric transmembrane site.
    Gill JK; Savolainen M; Young GT; Zwart R; Sher E; Millar NS
    Proc Natl Acad Sci U S A; 2011 Apr; 108(14):5867-72. PubMed ID: 21436053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular interactions of type I and type II positive allosteric modulators with the human α7 nicotinic acetylcholine receptor: an in silico study.
    Targowska-Duda KM; Kaczor AA; Jozwiak K; Arias HR
    J Biomol Struct Dyn; 2019 Feb; 37(2):411-439. PubMed ID: 29363414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interaction between alpha 7 nicotinic acetylcholine receptor and nuclear peroxisome proliferator-activated receptor-α represents a new antinociceptive signaling pathway in mice.
    Donvito G; Bagdas D; Toma W; Rahimpour E; Jackson A; Meade JA; AlSharari S; Kulkarni AR; Ivy Carroll F; Lichtman AH; Papke RL; Thakur GA; Imad Damaj M
    Exp Neurol; 2017 Sep; 295():194-201. PubMed ID: 28606623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macroscopic and Microscopic Activation of
    Quadri M; Garai S; Thakur GA; Stokes C; Gulsevin A; Horenstein NA; Papke RL
    Mol Pharmacol; 2019 Jan; 95(1):43-61. PubMed ID: 30348894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.